Welcome to Sleep Data, the only resource you need to diagnose and treat your patients’ sleep apnea to improve their overall health and wellness. We look forward to establishing trust by showcasing our professionalism and expertise so you are comfortable referring patients to us when you suspect they suffer from sleep apnea.

According to the New England Journal of Medicine, approximately 42 million American adults have sleep-disordered breathing (SDB), which describes four nocturnal breathing disorders:

  • Obstructive sleep apnea (OSA)
  • Central sleep apnea (CSA)
  • Nocturnal hypoventilation
  • Cheyne-Stokes respiration (CSR)


The Journal of the American Medical Association notes that 1 in 5 adults have mild OSA and 1 in 15 have moderate to severe cases. According to Sleep, 75% of severe SDB cases are undiagnosed.

The consequences of failing to treat sleep apnea can be deadly, since co-morbid diseases include cardiovascular issues, hypertension, type 2 diabetes and stroke:

  • 76% of congestive heart failure patients have SDB (as per the European Journal of Heart Failure)
  • 43% of patients with mild OSA and 69% of patients with severe OSA have hypertension (as per Sleep)
  • 48% of type 2 diabetes sufferers have sleep apnea (as per Endocrine Practice) and that number jumps to 86% when patients are obese (as per Diabetes Care)
  • 65% of stroke patients have SDB (as per Stroke)


In addition, Sleep notes that SDB is associated with a threefold increase in mortality risk and PLos Medicine reports that severe sleep apnea raises sufferers’ death risk by 46%. By partnering with Sleep Data to treat OSA early, physicians can help ensure patients do not become part of those troublesome statistics.

We invite you to learn more about SDB in the Learning Center.